Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Daiichi Sankyo
Age
40–85
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Idiopathic Parkinson's disease for at least 5 years
Presence of motor fluctuations and dyskinesia
Stable regimen of levodopa/carbidopa for 30 days
At least 25% response/improvement in Unified Parkinson's Disease Rating Scale (UPDRS) part III scores after dosing with regular Parkinson's disease (PD) medications
Mini-Mental State Examination (MMSE) score of 25 or higher
You may not be if
Atypical or secondary parkinsonism.
Prior use of neuroleptic agents.
History of intracranial procedures for PD.
Active psychosis.
History of drug or alcohol abuse in past 12 months.
Cardiac conduction system abnormality.
Predisposing medical condition that causes nausea or vomiting or routine use of an anti-emetic.
Clareo Health | Preliminary Study of Piclozotan in Patients With Motor Complications Associated With Parkinson's Disease
